Francisco Partners led the Series E round, which will support the company’s AI capabilities and pharmacy benefits platform.

The integration connects wearable health trends with Xella Health's diagnostic testing and physician-guided treatment.

Nervonik, a medical device company that develops peripheral nerve stimulation technologies, announced the close of an oversubscribed $52.5 million Series B funding round. Amzak Health led the round, ...

The Series D brings the company’s total capital raised to $430 million as it expands its clinical program, pursues further ...

A participant in Neuralink’s experimental VOICE study used the company’s brain-computer interface to generate speech in a ...

AI drug discovery and development company Iambic Therapeutics has filed for an initial public offering, according to a ...

Previous work in Auckland's Middlemore Hospital saw rostering time reduced to less than 20 hours per month from 120 hours per ...

The acquisition expands Hello Patient’s automation platform from patient communications to back-office tasks such as ...

Trained on MRI and ultrasound datasets, the AI framework correctly classified cases 83% of the time in early testing and ...

The pharmaceutical company will test Claude Science in research and development workflows and use Anthropic’s models to ...

Dr. Matthew Meyer, University of Virginia sustainable healthcare expert, says hospitals can reduce nitrous oxide and desflurane emissions without compromising patient care.

Life sciences organizations can apply to use the model with fewer safety guardrails for biology research through the ...